LYNPARZA Breast Cancer in the Adjuvant Setting Japan Post-Marketing Surveillance (PMS)
Clinical trial NCT05677308 · COMPLETED
Trial details
- NCT number
- NCT05677308
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2023-03-07
- Primary completion
- 2026-02-18
- Enrollment
- 61
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.